PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmultiple organ failure
MeSH D009102 - multiple organ failure
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012769:Shock
$
Success rate
D009102: 
Multiple organ failure
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Eli LillyDrotrecogin alfa (activated) Xigris  2002-08-22   
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
38%
5/13
Phase 3
0%
0/7
Approved: 0Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Eli Lilly
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use